Clin2
NCT05756179Possibly a fitRecruiting

Diosmin and hesperidin for mild to moderate rheumatoid arthritis

Rheumatoid Arthritis

Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.

This trial tests whether two natural plant-based medicines (diosmin and hesperidin) can reduce symptoms in people with mild to moderate rheumatoid arthritis. It compares treatment outcomes to standard care to see if these supplements help control the disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
80 people
Ages
19 years to 65 years
Study type
Interventional

Who can take part

  • Be 18 years or older
  • Have mild to moderate rheumatoid arthritis with not-too-high disease activity
  • Cannot be pregnant
  • Cannot be breastfeeding
  • Not have significant liver or kidney problems (or certain other inflammatory diseases)
  • Not currently take biologic “immune-blocking” medicines that target TNF-alpha or IL-1beta

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07566351Recruiting· Phase 2
Add-On Drugs for Rheumatoid Arthritis

This study tests whether two drugs—roflumilast and desloratadine—added to your current rheumatoid arthritis medications can reduce joint inflammation and pain. You'd take these as add-ons to your existing treatment to see if they help control your disease better.

Damietta, Damietta Governorate
NCT03770923Recruiting· Phase 3
Testing medicines for rheumatoid arthritis activity

This trial studies whether certain medicines can improve how active rheumatoid arthritis is. If you have rheumatoid arthritis and do not have significant liver or kidney problems, you may be able to join.

Tanta
NCT04748809Recruiting
Diet trial for rheumatoid arthritis inflammation

This study tests whether an anti-inflammatory diet can help people with rheumatoid arthritis by lowering inflammation and disease activity. You may join if your symptoms are currently mild to moderate and you haven’t recently changed medications or your treatment plan.

La Jolla, California
NCT06915701Recruiting· Phase 2/Phase 3
Vitamin E for rheumatoid arthritis inflammation

This study tests whether adding vitamin E to standard rheumatoid arthritis treatment can reduce inflammation and disease activity. It is designed for women with early RA who are not getting enough vitamin E from their diet.

Guadalajara, Jalisco
NCT07262112Not yet recruiting
Exercise and diet for rheumatoid arthritis

This study tests whether combining resistance exercise (like strength training) with an anti-inflammatory diet can help reduce pain, improve daily function, and boost quality of life for people with rheumatoid arthritis.

NCT07115641Not yet recruiting
Huoluo pills plus iguratimod for rheumatoid arthritis

This trial tests a combination of a traditional Chinese medicine (Huoluo Pills) and a Western drug (iguratimod) for people with moderate rheumatoid arthritis. It aims to see if the combination works better than either treatment alone.

Hear when a new Rheumatoid arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.